Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The planned study focuses on the effect of a one year Somatropin treatment (0.035 mg/kg/d or
0.067 mg/kg/d) in short children born SGA on neuromuscular function and cognitive
performance.